INVESTIGATING PROGRESSION-FREE SURVIVAL AS A POTENTIAL SURROGATE ENDPOINT FOR OVERALL SURVIVAL IN FIRST-LINE TREATMENT FOR GLIOBLASTOMA MULTIFORME: A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS

被引：0
|
作者：
Fu, A. [1 ]
Fazeli, M. S. [2 ]
Kanters, S. [2 ]
Siliman, G. [2 ]
Ma, Chaudhary [1 ]
Gogate, A. [1 ]
Kurt, M. [1 ]
机构：
[1] Bristol Myers Squibb, Lawrenceville, NJ USA
[2] Evidinno Outcomes Res Inc, Vancouver, BC, Canada
来源：
VALUE IN HEALTH | 2020年 / 23卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
CN4
引用
收藏
页码：S4 / S4
页数：1
相关论文
共 50 条
  • [1] Interpretation of meta-analysis evaluating progression-free survival as a surrogate endpoint for overall survival in glioblastoma
    Han, Kelong
    Ren, Melanie
    Wick, Wolfgang
    Abrey, Lauren
    Das, Asha
    Jin, Jin
    Reardon, David A.
    [J]. NEURO-ONCOLOGY, 2015, 17 (05) : 764 - 765
  • [2] Progression-free survival as surrogate endpoint in advanced pancreatic cancer: meta-analysis of 30 randomized first-line trials
    Petrelli, Fausto
    Coinu, Andrea
    Borgonovo, Karen
    Cabiddu, Mary
    Barni, Sandro
    [J]. HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2015, 14 (02) : 124 - 131
  • [3] Progression-free survival as surrogate endpoint in advanced pancreatic cancer: meta-analysis of 30 randomized first-line trials
    Fausto Petrelli
    Andrea Coinu
    Karen Borgonovo
    Mary Cabiddu
    Sandro Barni
    [J]. Hepatobiliary & Pancreatic Diseases International, 2015, 14 (02) : 124 - 131
  • [4] Progression-free survival as a surrogate endpoint for overall survival in modern ovarian cancer trials: a meta-analysis
    Sjoquist, Katrin M.
    Lord, Sarah J.
    Friedlander, Michael L.
    Simes, Robert John
    Marschner, Ian C.
    Lee, Chee Khoon
    [J]. THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2018, 10 : 1 - 16
  • [5] Progression-free survival as a surrogate endpoint for overall survival in glioblastoma: a literature-based meta-analysis from 91 trials
    Han, Kelong
    Ren, Melanie
    Wick, Wolfgang
    Abrey, Lauren
    Das, Asha
    Jin, Jin
    Reardon, David A.
    [J]. NEURO-ONCOLOGY, 2014, 16 (05) : 696 - 706
  • [6] A meta-analysis of randomized, controlled trials in metastatic melanoma establishes progression-free survival as a surrogate for overall survival
    Flaherty, K. T.
    Lee, S. J.
    Dummer, R.
    Hauschild, A.
    Hennig, M.
    Long, G. V.
    Lorigan, P.
    Robert, C.
    Schadendorf, D.
    [J]. EUROPEAN JOURNAL OF CANCER, 2013, 49 : S856 - S856
  • [7] META-ANALYSIS OF THE VALIDITY OF PROGRESSION-FREE SURVIVAL AS A SURROGATE ENDPOINT FOR OVERALL SURVIVAL IN METASTATIC COLORECTAL CANCER TRIALS
    Chirila, C.
    Odom, D. M.
    Devercelli, G.
    Khan, S.
    Sherif, B. N.
    Kaye, J. A.
    Molnar, I.
    Sherrill, B. H.
    [J]. ANNALS OF ONCOLOGY, 2010, 21 : 202 - 202
  • [8] PROGRESSION-FREE SURVIVAL (PFS) AS A SURROGATE ENDPOINT FOR OVERALL SURVIVAL (OS) IN PREVIOUSLY UNTREATED ADVANCED MELANOMA: A CORRELATION META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS (RCTS)
    Leung, L.
    Chou, E.
    Kurt, M.
    Moshyk, A.
    Hamilton, M.
    Pourrahmat, M. M.
    Kanters, S.
    [J]. VALUE IN HEALTH, 2022, 25 (01) : S22 - S22
  • [9] Progression-Free Survival as a Surrogate Endpoint for Median Overall Survival in Metastatic Colorectal Cancer: Literature-Based Analysis from 50 Randomized First-Line Trials
    Giessen, Clemens
    Laubender, Ruediger Paul
    Ankerst, Donna Pauler
    Stintzing, Sebastian
    Modest, Dominik Paul
    Mansmann, Ulrich
    Heinemann, Volker
    [J]. CLINICAL CANCER RESEARCH, 2013, 19 (01) : 225 - 235
  • [10] Progression-free survival as a surrogate endpoint for hazard ratio and median overall survival in glioblastoma: A literature-based meta-analysis from 91 trials
    Han, K.
    Ren, M.
    Wick, W.
    Jin, J.
    Abrey, L.
    Das, A.
    Reardon, D.
    [J]. EUROPEAN JOURNAL OF CANCER, 2013, 49 : S775 - S776
12345